SCHEMBL356738

SCHEMBL356738

C[N+](C)(C)C(CC(=O)O)C(=O)[O-]

nearest known ligand 0.52

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
POLB P06746 2/20 0.52
ALPL P05186 1/20 0.52
ALPG P10696 1/20 0.52
MAPT P10636 1/20 0.41
ALOX15 P16050 1/20 0.41
SLC22A4 Q9H015 1/20 0.39
SLC22A16 Q86VW1 1/20 0.37
SLC22A6 Q4U2R8 1/20 0.36
GAA P10253 1/20 0.36
BBOX1 O75936 1/20 0.35
TSHR P16473 1/20 0.35
TDP1 Q9NUW8 1/20 0.35
CPT2 P23786 1/20 0.34
CPT1A P50416 1/20 0.34
LMNA P02545 2/20 0.34
SMN1; SMN2 Q16637 2/20 0.34
ALDH1A1 P00352 1/20 0.33
APEX1 P27695 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9548441 0.80 ALPL (0.39) POLBALPLALPGMAPTALOX15
SCHEMBL28224456 0.80 MAPT (0.44) POLBALPLALPGMAPTALOX15
SCHEMBL1005600 0.77 POLB (0.48) POLBALPLALPGSLC22A4GAA
SCHEMBL19618631 0.76 POLB (0.43) POLBALPLALPGSLC22A4SLC22A16
SCHEMBL1427298 0.75 POLB (0.50) POLBALPLALPGSLC22A4SLC22A16
Acetic Acid SCHEMBL3682296 0.74 POLB (0.50) POLBALPLALPGALOX15SLC22A4
SCHEMBL285029 0.74 ALPL (0.46) POLBALPLALPGSLC22A6BBOX1
Hydrochloric Acid SCHEMBL25181737 0.73 POLB (0.48) POLBALPLALPGSLC22A4SLC22A16
SCHEMBL31019233 0.72 GPR84 (0.43) MAPTALOX15SLC22A6TSHRTDP1
Tetramethylammonium Ion SCHEMBL106073 0.71 MAPT (0.41) MAPTALOX15SLC22A16SLC22A6BBOX1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 203 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230338324-A1 METHOD FOR TREATING RHEUMATOID ARTHRITIS THE WILLIAM M YARBROUGH FOUNDATION 2023-10-26 US claimed
WO-2020208052-A1 METHOD FOR PROVIDING LAUNDRY DETERGENT WITH CONTROL AND A LAUNDRY APPARATUS AND A LAUNDRY DETERGENT KIT BASF SE (DE) 2020-10-15 WO claimed
CN-110845953-A Exterior wall environment-friendly coating and preparation method thereof 青川源泰建材科技有限公司 2020-02-28 CN claimed
CN-109897745-A Composition of skin cleanser and preparation method thereof 株式会社LG生活健康 2019-06-18 CN claimed
CN-109640933-A Both sexes acetate and beet alkali surface activator containing potassium 罗地亚经营管理公司 2019-04-16 CN claimed
WO-2018148612-A1 COMPOSITIONS CONTAINING A FLEXIBLE DERIVED CAPSULE WITH AN ACTIVE AGENT CoLabs International Corporation (US) 2018-08-16 WO claimed
CN-1875091-B Soap bar composition with reduced soap bar wear properties COLGATE PALMOLIVE CO 2013-10-30 CN claimed
CN-102964260-A Preparation method of N,N-dimethyl-N-fatty alcohol polyethenoxy ether-base carboxymethyl lycine UNIV JIANGNAN 2013-03-13 CN claimed
EP-1119339-B1 STABILIZED SHAMPOO CONTAINING SILOXYSILICATE MATERIAL COLGATE PALMOLIVE CO (US) 2007-09-26 EP claimed
EP-1395235-B1 SHAMPOOS WITH BEHENYL ALCOHOL COLGATE PALMOLIVE CO (US) 2007-02-28 EP claimed
CN-1875091-A Composition with reduced bar wear COLGATE PALMOLIVE CO (US) 2006-12-06 CN claimed
EP-1395235-A2 SHAMPOOS WITH BEHENYL ALCOHOL Colgate-Palmolive Company (US) 2004-03-10 EP claimed
CN-1125880-C Method for processing mycobacteria INTEGRATED RES TECH PLC (US) 2003-10-29 CN claimed
WO-2002100362-A2 SHAMPOOS WITH BEHENYL ALCOHOL COLGATE-PALMOLIVE COMPANY (US) 2002-12-19 WO claimed
CN-1264430-A Betaines as adjuvants to susceptibility testing and antimicrobial therapy INTEGRATED RES TECHNOLOGY PLC (US) 2000-08-23 CN claimed
CN-1150460-A Method for processing mycobacteria CORNING CLINICAL LAB INC (US) 1997-05-21 CN claimed
US-4122043-A BUILDERS, CHELATING OR SEQUESTERING AGENTS POLYTROL CHEMICAL CORPORATION (US) 1978-10-24 US claimed
WO-2024149652-A1 BLENDS OF AMIDOPROPYL BETAINES DERIVED FROM FATTY ACID MIXTURES COMPRISING UNSATURATED FATTY ACIDS AND ALK(EN)YL (POLY)GLYCOSIDES BASF SE (DE) 2024-07-18 WO disclosed
EP-0079197-B1 POLYMER COMPOSITIONS Saegusa, Takeo (JP) 1987-10-14 EP disclosed
US-4122043-A BUILDERS, CHELATING OR SEQUESTERING AGENTS POLYTROL CHEMICAL CORPORATION (US) 1978-10-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230338324-A1 METHOD FOR TREATING RHEUMATOID ARTHRITIS MIF, TNF, MMP12 POLB 2722/4885ALPL 2249/4885ALPG 3818/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.